MarketsStocksKILITCH
KI

Kilitch Drugs (India) Limited

NSE: KILITCHBSE: 524500Healthcare
Download Research Report7-page PDF
167.00
-3.86%
NSE · auto-updates while market open
Prev Close
₹217.25
Day High
₹173.70
Day Low
₹164.80
Mkt Cap
₹586 Cr
P / E
19.9
P / B
2.1
ROE
12.2%
52W High
₹250.00
52W Low
₹117.25
Key Metrics
Market Cap
₹586 Cr
P / E
19.87
P / B
2.09
EV / EBITDA
18.56
ROCE
14.3%
ROE
12.2%
Debt / Equity
0.32
Book Value
₹79.99
EPS
₹8.91
Div Yield
0.0%
Face Value
₹10
Promoter Holding
63.8%
Revenue · ₹ Cr
53
FY20
69
FY21
114
FY22
140
FY23
154
FY24
198
FY25
235
FY26
Net Profit · ₹ Cr
1
FY20
4
FY21
6
FY22
8
FY23
14
FY24
25
FY25
30
FY26
EPS · ₹ per share
₹0.6
FY20
₹2.4
FY21
₹4.7
FY22
₹6.7
FY23
₹9.2
FY24
₹16.6
FY25
₹8.9
FY26
P / E Ratio · price ÷ TTM EPS
32240591990-1Jun 21Feb 23Oct 24Jun 26
P/E 12.3×Median 17.1×TTM EPS
Q1 2026 snapshot
Sales
₹90 Cr
Operating profit
-
OPM
-
Net profit
₹15 Cr
EPS
₹4.24
Scorecard · 7 axes
Quality
Strong
78/100
Valuation
Good
19.9×
Growth
Strong
+33.7%
Profitability
Avg
13.3%
Performance
Bad
-19.9%
Entry Point
Good
67%
Red Flags
Strong
0 flags
Shareholding Pattern
63.8%Promoter
Promoter63.8%
Public36.2%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue56.1762.9245.755.5855.3490.1
Net Profit5.6110.2192.2638.044.31514.883
NPM %10.0%16.2%5.0%14.5%7.8%16.5%
AlertPre-trade